Offices:
Tampere
Investors:
we tracked 3 investors
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Total investments received (USD) - we tracked 1 transaction
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
BioMensio Ltd is a Hermia Science Park based biotechnology company in Tampere, Finland.
The company was recently established to build on international research programs and intellectual property of more than 15 patent families.
Core of the BioMensio biosensor platform is an innovative mass-sensitive microarray technology, which is based on joint research and development by Siemens AG and VTT Technical Research Centre of Finland Ltd. The BioMensio devices allow frequent and rapid on-site detection of multiple biological targets from a small amount of sample in one step.
Companies with similar profile to BioMensio:
| Company | Criteria |
|---|
 Desentum55% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: VTT Ventures
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| Paptic 44% | - Similar business models: B2B
- At least one vc investor: VTT Ventures
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| Oppex 44% | - Similar business models: B2B
- At least one vc investor: Tekes
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| Asqella 44% | - Similar business models: B2B
- At least one vc investor: VTT Ventures
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| LymphaTouch 44% | - Similar business models: B2B
- At least one vc investor: Tekes
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| Sulapac 44% | - Similar business models: B2B
- At least one vc investor: Tekes
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| Aiforia 44% | - Similar business models: B2B
- At least one vc investor: Tekes
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| Transfluent 44% | - Similar business models: B2B
- At least one vc investor: Tekes
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| FocalSpec 44% | - Similar business models: B2B
- At least one vc investor: VTT Ventures
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| TactoTek 44% | - Similar business models: B2B
- At least one vc investor: VTT Ventures
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| Noccela 44% | - Similar business models: B2B
- At least one vc investor: Tekes
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
 Scandinavian Real Hearts43% | - Similar verticals: Biotech
- Similar business models: B2B
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
 Acesion Pharma43% | - Similar verticals: Biotech
- Similar business models: B2B
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| MetGen 43% | - Similar verticals: Biotech
- Similar business models: B2B
- Total raised in a similar range: 1M - 5M USD
- Minim one investor from outside Scandinavia: Yes
|
| Aurealis Pharma 35% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Tekes
|
| TILT Biotherapeutics 35% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Tekes
|
| Bonusway 34% | - Similar business models: B2B
- At least one vc investor: Tekes
- Minim one investor from outside Scandinavia: Yes
|
| Synoste Oy 34% | - Similar business models: B2B
- At least one vc investor: Tekes
- Minim one investor from outside Scandinavia: Yes
|
| OceanVolt 34% | - Similar business models: B2B
- At least one vc investor: Tekes
- Total raised in a similar range: 1M - 5M USD
|
| Oura Health 34% | - Similar business models: B2B
- At least one vc investor: Tekes
- Minim one investor from outside Scandinavia: Yes
|
